Skip to content

Trichoscopy and Systemic Scleroderma

Prognostic Value of Trichoscopy in Patients With Systemic Scleroderma

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04804930
Acronym
TRICHLOSCLERO
Enrollment
200
Registered
2021-03-18
Start date
2021-11-08
Completion date
2026-05-01
Last updated
2026-04-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Scleroderma, Systemic

Keywords

Trichoscopy, Dermoscopy, Systemic Scleroderma, Scalp

Brief summary

* Few data are available on scalp involvement in systemic scleroderma. * Few data are available on the association between scalp abnormalities and features of systemic scleroderma * Trichoscopy is a simple, reproducible, noninvasive examination that is part of the examination of hairy areas in routine dermatologic practice * There is a lack of simple, noninvasive examinations to evaluate patients with systemic scleroderma The objective will be to evaluate the contribution of trichoscopy in the evaluation of patients with systemic scleroderma

Interventions

PROCEDUREpicture

We will perform a non-invasive assessment of the scalp with a dermoscope by taking two standardized pictures on the frontal area and the occipital area in order to a blinded analysis of trichoscopic patterns

Sponsors

University Hospital, Lille
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patient who fulfils the Systemic scleroderma ACR-EULAR 2013 criteria * Signed informed consent * Being social insured

Exclusion criteria

* Patients aged less than 18 years old * patients under legal protection * patients deprived of their liberty * patients in emergency situations * patients who refused or unable to give informed consent * For the control group: sclap inflammatory disease active the day of the examination

Design outcomes

Primary

MeasureTime frameDescription
Frequency of elementary lesions observed by trichoscopic assessment of the scalpBaselineComparison of the frequencies of elementary lesions visualized in patients with systemic scleroderma and healthy subjects

Secondary

MeasureTime frameDescription
Correlation between visceral damage of systemic scleroderma and trichoscopic featuresBaselineFrequency of visceral damage of systemic scleroderma: pulmonary hypertension, lung fibrosis, kidney failure.
Correlation between global severity of systemic scleroderma and trichoscopic featuresBaselineCorrelation between EUSTAR score, Rodnan score, Medsger's score and trichoscopic features
Correlation between autoimmune profile of sclerodermic patients and trichoscopic featuresBaselineCorrelation of antibodies, inflammatory profile of patients with trichoscopic features.

Countries

France

Contacts

CONTACTVincent Sobanski, MD
vincent.sobanski@chru-lille.fr0320445962
PRINCIPAL_INVESTIGATORVincent Sobanski, MD

University Hospital, Lille

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 23, 2026